In this 60-minute webinar, Dr. Tenaerts presents the work of the Clinical Trials Transformation Initiative (CTTI) and discusses two main topics regarding digital clinical trials: (1) moving ongoing trials to remote and (2) planning for decentralized trials. Learning Objectives  By the end of this webinar, participants will be able to Recognize how the trials community has pivoted to virtual and remote visits for ongoing trials. Identify CTTI’s recommendations for digital health trials and decentralized clinical trials. Speakers Dr. Pamela Tenaerts, M.D. Pamela Tenaerts, MD, MBA is executive director at the Clinical Trials Transformation Initiative (CTTI) where she works closely with the Executive Committee to develop and implement strategies to accomplish the organization’s mission. She orchestrates efforts to effectively engage all interested stakeholders to improve the conduct of clinical trials. She is on the Board of Directors for the Society of Clinical Trials and a member of DIA’s Advisory Council North America and DiMe Society’s Scientific Advisory Board. Dr. Tenaerts is an independent director on the board of TRxADE Group, Inc. She practiced medicine in both the emergency department and in a private practice setting before embarking on a career in research. Dr. Tenaerts has obtained Six Sigma Green Belt certification. Disclaimer: The presenter is an Employee of Duke University. Salary support comes from pooled membership fees of the Clinical Trials Transformation Initiative and from FDA Cooperative agreement and is an independent first of the board of TRxADE, inc. Additional Information: <a href="https://www.ctti-clinicaltrials.org/">https://www.ctti-clinicaltrials.org/</a>